Pharmacokinetics and probability of target attainment for micafungin in normal-weight and morbidly obese adults

Abstract Objectives The rising pandemic of obesity means an increasing number of obese patients who require antimicrobial therapy for serious infections. Micafungin is an echinocandin drug frequently used as therapy or prophylaxis for fungal infections, predominantly with Candida species. In order t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antimicrobial chemotherapy 2019-04, Vol.74 (4), p.978-985
Hauptverfasser: Wasmann, Roeland E, Smit, Cornelis, ter Heine, Rob, Koele, Simon E, van Dongen, Eric P H, Wiezer, René M J, Burger, David M, Knibbe, Catherijne A J, Brüggemann, Roger J M
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!